Cita APA

Guarimata, J. D., & Lavecchia, M. J. (2024). In Silico Study of FDA-Approved Drugs on Leishmania infantum CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis. Web

Citación estilo Chicago

Guarimata, Juan Diego, and Martín José Lavecchia. In Silico Study of FDA-Approved Drugs On Leishmania Infantum CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis. 2024.

Cita MLA

Guarimata, Juan Diego, and Martín José Lavecchia. In Silico Study of FDA-Approved Drugs On Leishmania Infantum CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis. 2024.